Document is current
Any future updates will be listed below
-
Authors
Piraccini, Bianca Maria
Vañó-Galván, Sergio
Blume-Peytavi, Ulrike
Ribet, Virginie
Mengeaud, Valérie https://orcid.org/0000-0001-8585-3974
-
Funding
Funding for this research was provided by:
Pierre Fabre Dermo-Cosmétique & Personal Care
- License Information
-
More Information
Article History
Received: 31 March 2026
Accepted: 8 May 2026
First Online: 5 June 2026
Declarations
:
: Bianca Maria Piraccini has been a speaker and/or consultant for Almirall, Difa Cooper, Dercos-L’Oreal, Eli Lilly, ISDIN, Legacy Healthcare, Pierre Fabre-Ducray, Giuliani, Olistic, Pfizer. Sergio Vañó-Galván has received honoraria for lectures and consulting fees for acting as an advisor from Pierre Fabre. Ulrike Blume-Peytavi has been a speaker and/or consultant for Abbvie, Almirall, Cantabria Labs, Cassiopeia, CeraVe, Concert Pharmaceuticals/Sun Pharma, Cosmopharma, Dermocosmétique Vichy, Galderma Laboratorium GmbH, Eli Lilly, Legacy Healthcare, LEO-Pharma, Novartis, Pfizer, Sanofi Regeneron. Virginie Ribet and Valérie Mengeaud are employees of Pierre Fabre.
: Information presented in this article is based on previously conducted studies and it does not contain data from new studies with human participants or animals performed by any of the authors.
